By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eleven Biotherapeutics 



Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
Eleven Biotherapeutics (EBIO) To Present Data At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/29/2016 10:37:35 AM
Eleven Biotherapeutics (EBIO) Reports Fourth Quarter And Full Year 2015 Financial Results And Provides Strategic Update 3/24/2016 7:59:17 AM
Struggling Eleven Biotherapeutics (EBIO) Gets Delisting Notice from Nasdaq After Back-to-Back Clinical Trial Failures 3/10/2016 6:07:38 AM
Albumedix And Eleven Biotherapeutics (EBIO) Announce Albumin Variant Technology Agreement 1/26/2016 10:18:47 AM
Eleven Biotherapeutics (EBIO) Stock Plunges on Yet Another Failed Clinical Trial 1/18/2016 6:11:57 AM
Eleven Biotherapeutics (EBIO) Reports Third Quarter 2015 Financial Results 11/4/2015 10:57:14 AM
Eleven Biotherapeutics (EBIO) To Report Third Quarter 2015 Financial Results On November 4, 2015 10/27/2015 10:56:52 AM
Eleven Biotherapeutics (EBIO) Completes Enrollment In Pivotal Phase III Study Of Isunakinra (EBI-005) In Patients With Allergic Conjunctivitis 10/15/2015 8:15:10 AM
Eleven Biotherapeutics (EBIO) Announces Promotions Of Gary Sternberg, MD, MBA To Chief Business Officer And John Mccabe, CPA To Senior Vice President, Finance 9/1/2015 9:00:20 AM
Eleven Biotherapeutics (EBIO) To Present At NewsMakers In The Biotech Industry Conference 8/31/2015 8:48:26 AM
12345678
//-->